Utrecht University

Overview

The College of Pharmaceutical Sciences (CPS) at Utrecht University offers a three-year Honours Bachelor's programme focused on Drug Development. This programme provides students with the knowledge and skills necessary to understand how new medicines are designed, tested, and transformed from scientific theories into safe and effective therapies.

• Level: Honours Bachelor’s (3 years)
• Programme focus: Drug discovery and development
• Delivery: Full-time, on-campus (Utrecht University)
• Language of instruction: English
• Credits: Typically 180 ECTS (3-year bachelor)
• International orientation: Designed for students from various nationalities
• English test options: IELTS or TOEFL iBT

What you'll study

The curriculum integrates core scientific courses with practical skills and advanced academic work. The following course titles highlight the main themes explored throughout the programme:

• Epidemiology and Clinical Development
• Behaviour of the Drug in the Human Body
• The Drug and the Cell
• The Drug Molecule
• Intercellular Communication
• Immunopharmacology

Learning approach: The programme emphasizes small-group learning and an Honours-level academic environment, fostering active participation and a deeper understanding of drug development.

Capstone / final work: The programme culminates in an academic component typical of bachelor Honours tracks, which may include a thesis or project. Please refer to the official CPS programme page for details regarding the specific format based on your intake.

Entry requirements

While there are no specific GRE, GMAT, or GPA grading score requirements for this programme, students are encouraged to verify their eligibility and prepare accordingly.

Career prospects

Graduates of the College of Pharmaceutical Sciences can pursue a variety of career paths in the pharmaceutical and biotechnology industries, as well as in academic and research institutions. The knowledge and skills gained during the programme equip students to contribute effectively to the development of innovative therapies and improve patient outcomes.